Hara Capital’s Bristol-Myers Squibb BMY Stock Holding History

Hara Capital’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$78.4K	Sell	1,360 -550	-29%	-$31.6K	0.04%	165
2026 Q1	$116K	Hold	1,910	–	–	0.06%	144
2025 Q4	$103K	Sell	1,910 -200	-9%	-$9.62K	0.06%	147
2025 Q3	$95.2K	Sell	2,110 -451	-18%	-$21.1K	0.06%	145
2025 Q2	$119K	Sell	2,561 -5,806	-69%	-$285K	0.07%	150
2025 Q1	$510K	Sell	8,367 -1,964	-19%	-$114K	0.34%	69
2024 Q4	$584K	Sell	10,331 -330	-3%	-$18.4K	0.37%	68
2024 Q3	$552K	Sell	10,661 -695	-6%	-$32.6K	0.34%	71
2024 Q2	$472K	Sell	11,356 -26	-0.2%	-$1.16K	0.3%	83
2024 Q1	$617K	Sell	11,382 -145	-1%	-$7.39K	0.37%	59
2023 Q4	$591K	Buy	+11,527	New	+$605K	0.42%	51

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Hara Capital's BMY Position: Q2 2026 in Review

Hara Capital reduced its Bristol-Myers Squibb (BMY) stake by 29% in Q2 2026, selling an estimated $31.6K and leaving 1,360 shares worth $78.4K. The position accounts for 0.04% of the portfolio, ranked #165.

Hara Capital first reported a position in BMY in Q4 2023 and has held it in 11 quarters since. The position peaked at $617K in Q1 2024. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Hara Capital held 1,360 shares of Bristol-Myers Squibb worth $78.4K as of Q2 2026.
Hara Capital sold 550 Bristol-Myers Squibb shares in Q2 2026, an estimated $31.6K.
Bristol-Myers Squibb made up 0.04% of Hara Capital's portfolio in Q2 2026, its #165 holding.
Hara Capital first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 11 quarters since.
Hara Capital's Bristol-Myers Squibb position peaked at $617K in Q1 2024.
2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Hara Capital's 13F filing for Q2 2026, filed 11 Aug 2026.